Top Markets
#1 ICON ICON +156.44%
#2 ZetaChain ZetaChain +47.92%
#3 Four Four +39.72%
#4 Phala Phala +34.53%
#5 Chia Chia +33.77%
#6 Mubarak Mubarak +32.15%
#7 Nano Nano +27.88%
#8 SODAX SODAX +26.10%
#9 Bitway Bitway +24.95%
#10 PumpMeme PumpMeme +23.83%
Coin of the day
ICON ICON
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Zoetis Inc. Zoetis Inc.

Zoetis Inc.

ZTS
Clasificación en acciones #830
Zoetis Inc. stands as a global leader in animal health, focusing on the... Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Precio por acción
$71.40
Capitalización bursátil
$29.93B
Cambio (1 día)
-0.13%
Cambio (1 año)
-51.06%
País
US
Comercio Zoetis Inc. (ZTS)

Categoría

Healthcare
Número de acciones en circulación de Zoetis Inc. (ZTS)
Número de acciones en circulación al June 2026: 417.60M
Según los últimos informes financieros y el precio de las acciones de Zoetis Inc., el número actual de acciones en circulación es 417.60M. Al final de December 2024, la empresa tenía 454.20M acciones en circulación. El número de acciones en circulación generalmente se ve afectado por divisiones de acciones y recompras.
Historial de acciones en circulación de Zoetis Inc. (ZTS) desde 2009 hasta 2026
Acciones en circulación al final de cada año
Año Acciones en circulación Cambiar
2026 (TTM) 417.60M -5.83%
2025 443.44M -2.37%
2024 454.20M -1.51%
2023 461.17M -1.65%
2022 468.89M -1.15%
2021 474.35M -0.24%
2020 475.50M -0.55%
2019 478.13M -1.02%
2018 483.06M -1.40%
2017 489.92M -1.17%
2016 495.72M -0.80%
2015 499.71M -0.27%
2014 501.06M 0.21%
2013 500.00M 0.00%
2012 500.00M 4.57%
2011 478.13M 0.00%
2010 478.13M 0.00%
2009 478.13M 0.00%
Acciones en circulación de empresas similares o competidores
Empresa Acciones en circulación Diferencia País
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M 113.70%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 2.44B 484.33%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B 324.09%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M 90.61%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 0.00 -100.00%
US